Search Results

Zhongji Flash e-Flash 200A Enters Innovative Medical Device Special Review Program

Recently, the public notice period for the review results of applications for the Innovative Medical Device Special Review Program by the Center for Medical Device Evaluation of the National Medical Products Administration has concluded. The ultra-high dose rate electron beam radiotherapy system (e-Flash 200A), independently developed by Zhongji Flash Medical Technology Co., Ltd., has officially entered the Innovative Medical Device Special Review Program. According to reports, the e-Flash 200A is China's first ultra-high dose rate electron beam FLASH radiotherapy device and had previously been included in the "Global New" green channel. Its entry into the Innovative Medical Device Special Review Program signifies further recognition of the product's technological innovation and clinical application value. The system is designed for superficial tumor radiothe...

2026-08-04

CGN Guangdong Taipingling Nuclear Power Project Unit 2 Officially Commences Commercial Operation

On August 3, CGN Guangdong Taipingling Nuclear Power Project Unit 2 officially commenced commercial operation, marking the full completion of the Phase I project of the first Hualong One self-developed third-generation nuclear power project in the Guangdong-Hong Kong-Macao Greater Bay Area. Located in Huidong County, Huizhou City, Guangdong Province, the Taipingling Nuclear Power Project's Phase I includes Units 1 and 2, which received national approval on April 8, 2019. Among them, Unit 1 of the project commenced commercial operation in April this year. The construction team fully leveraged experience from previous Hualong One projects, successively completing a series of major engineering milestones including nuclear island main structure construction, equipment installation and commissioning, nuclear fuel loading, first criticality of the reactor, and grid connection for power generation, with steady improvements in project construction quality, safety levels, and construction efficiency...

2026-08-03

Pre-Startup Review (PSUR) for Sanmen Nuclear Power Plant Unit 3 Completed

From July 15 to 30, the Pre-Startup Review (PSUR) for Sanmen Nuclear Power Plant Unit 3 was conducted at the Sanmen nuclear power plant site. The review was organized by the Shanghai Office of the World Association of Nuclear Operators (WANO), and the review team consisted of 21 experts from the WANO Shanghai Office, WANO Tokyo Center, and Korea Hydro & Nuclear Power Co., Ltd. Leaders of Sanmen Nuclear Power Company and personnel from relevant fields participated in this activity. The review aimed to systematically and comprehensively evaluate the readiness of Unit 3 prior to startup, identify areas for improvement, analyze causes, and propose improvement recommendations. Through site inspections, work observations, document package reviews, and personnel interviews, the WANO review team conducted a thorough assessment of...

2026-08-03

Japanese research team experimentally demonstrates that fusion plasma fluctuations can drive inward particle transport

August 3, 2026, a research team from The University of Tokyo and the National Institute for Fusion Science (NIFS) under the National Institutes of Natural Sciences announced that researchers have directly observed in experiments that low-frequency electric field fluctuations in high-temperature plasma confined by a dipole magnetic field can transport particles to the central region of the plasma. Plasma produced by the levitated dipole experiment device RT-1 (Ring Trap 1) Overall view of the RT-1 device (Kashiwa Campus, The University of Tokyo) The study was conducted using the levitated dipole experiment device Ring Trap 1 (RT-1) at The University of Tokyo. RT-...

2026-08-03

Ratio Therapeutics Completes $70 Million Series C Financing to Advance Clinical Development of Ac-225 Targeted Radiopharmaceuticals

Ratio Therapeutics, Inc., a U.S. clinical-stage pharmaceutical company, recently announced the completion of a $70 million Series C financing round. The company stated that following this round, its cumulative total financing has exceeded $240 million. According to the announcement, this round saw participation from existing investors Duquesne Family Office and Bristol Myers Squibb, while also bringing in new investors such as Catalio Capital Management, Eli Lilly and Company, and Wasatch Group. Ratio Therapeutics stated that the proceeds will be used to advance the clinical development of its targeted radiotherapeutic product pipeline and expand manufacturing infrastructure. The company plans to continue advancing the ATLAS study, which is evaluating its lead radiotherapeutic agent [Ac-2...

2026-08-03

Wang Min, Deputy Director of the China International Nuclear Fusion Energy Program Execution Center, Led a Delegation to Thailand and Malaysia to Attend China-Thailand and China-Malaysia Bilateral Science and Technology Cooperation Consultations on Nuclear Fusion

To fully implement the spirit of China's Belt and Road Initiative, implement the Memorandum of Understanding between China and Thailand on jointly strengthening nuclear fusion exchange and cooperation, and advance research and development cooperation in the field of nuclear fusion between China and Thailand and between China and Malaysia, the China-Thailand and China-Malaysia bilateral science and technology cooperation consultations on nuclear fusion were held in Bangkok and Kuala Lumpur respectively from July 27 to 30. Wang Min, Deputy Director of the Nuclear Fusion Center, led a delegation to attend the meetings. At the China-Thailand consultation, the two sides engaged in in-depth discussions on their respective national fusion research and development progress, how to implement the newly signed Memorandum of Understanding on jointly strengthening nuclear fusion exchange and cooperation, and matters such as jointly conducting fusion physics experimental research, personnel exchange visits, and talent cultivation based on the TT-1 tokamak device donated by China.

2026-08-03

Montpellier, France, tests control of tiger mosquitoes by releasing 200,000 X-ray-sterilized males weekly

Montpellier, France, is testing a mosquito control strategy that does not rely on chemical insecticides by releasing X-ray-sterilized sterile male tiger mosquitoes, in response to the spread of tiger mosquitoes and the associated disease transmission risks. The trial has been underway since 2025 in the Malbosc residential area of Montpellier. This area is suitable for tiger mosquito breeding, and the trial team releases sterile male tiger mosquitoes at approximately 30 release points twice a week, about 100,000 per release, equivalent to roughly 200,000 per week across an area of about 50 hectares. The method is based on the sterile insect technique. Since only female mosquitoes bite and suck blood and may transmit viruses, and females typically mate only once in their lifetime, researchers release male mosquitoes that have lost their reproductive capacity after X-ray treatment into the wild to mate with wild females. The eggs subsequently laid by females fail to fertilize normally, thereby reducing the next generation of mosquito populations.

2026-08-03

United Imaging Healthcare's New-Generation Digital PET/CT "uMI Panvivo" Enters Clinical Use in Japan

August 3 news, United Imaging Healthcare Japan Co., Ltd. announced that the first unit in Japan of its new-generation digital PET/CT scanner uMI Panvivo has been put into clinical use at Saitama Central Clinic, located in Omiya-ku, Saitama City. Saitama Central Clinic is a medical institution specializing in diagnostic imaging. Since its opening in 2009, the clinic has continuously conducted comprehensive cancer screening centered on PET/CT scans, and provides FDG-PET cancer examination services based on the needs of local medical institutions, with an annual PET/CT examination volume ranking among the highest in Japan. With the introduction of uMI Panvivo, the clinic expects to further shorten examination time and enhance image quality on the basis of its existing high-precision diagnostic imaging...

2026-08-03

South Korea's Deepnoid Signs M4CXR Supply Contract with Pusan National University Hospital

On August 3, Deepnoid announced the signing of a supply contract for M4CXR with Pusan National University Hospital. M4CXR is a generative AI-based preliminary report generation solution for chest X-rays that generates preliminary reports during chest X-ray examinations to assist medical staff in image interpretation. This is the first supply agreement signed after M4CXR received approval from the Ministry of Food and Drug Safety of South Korea for market release as a digital medical device. According to the introduction, the system is expected to improve the efficiency of chest X-ray reading and provide clinical support for the early detection of lung diseases and suspected cancerous lesions. This collaboration is also part of the AI clinical system support project for regional responsible medical institutions under the Ministry of Health and Welfare of South Korea...

2026-08-03

Dutch ULC-Energy and US McDermott sign cooperation agreement to advance Rolls-Royce SMR deployment in the Netherlands

Dutch nuclear development company ULC-Energy and US engineering and construction firm McDermott announced on August 2 the signing of a cooperation agreement to support the project development of Rolls-Royce Small Modular Reactors (SMR) in the Netherlands. The cooperation includes integrating SMR energy supply solutions with energy-intensive industrial processes, leveraging McDermott's experience in energy transition and industrial decarbonization (low-carbon hydrogen, ammonia, sustainable aviation fuel, carbon capture and utilization), combined with ULC-Energy's nuclear project development capabilities. The two parties previously collaborated in 2023 to study industrial hydrogen production using "Rolls-Royce SMR + solid oxide electrolyzer," with ULC coordinating and McDermott providing engineering design and cost information for thermal integration/plant layout systems. McDermott's Senior Vice President of Low Carbon Solutions, Rob Shaul, stated that the agreement consolidates the existing relationship and reflects a shared commitment to advancing low-carbon energy in the Netherlands; the company has a long-standing presence in the country with its Hague center supporting projects across Europe. ULC-Energy CEO Dirk Rabelink noted that nuclear energy is effective when integrated into the energy system, and that SMRs flexibly supply electricity, heat, and hydrogen, with earlier cooperation having demonstrated this pathway, expressing hope to expand to other applications.

2026-08-03

New Progress in First-Principles Quantum Computing for Nuclear Structure

Recently, the research team at the Institute of Modern Physics, Chinese Academy of Sciences, has made new progress in quantum computing studies of first-principles nuclear structure for multi-fermion systems. The team developed a universal quantum-classical hybrid computing framework capable of calculating Green's functions and spectral functions of nuclear many-body systems. The relevant results were published as a Letter in Physical Review C. First-principles Hamiltonian many-body calculations are a core approach for revealing the laws of strongly correlated quantum systems, widely applied in fields such as quantum chemistry and nuclear physics. However, the Hilbert space of such problems grows exponentially with particle number, posing insurmountable computational resource challenges on classical computers...

2026-08-03

New Progress in Ion Dynamics Regulation in Nanofluidic Memristors by the Institute of Modern Physics, Chinese Academy of Sciences

Water-based nanofluidic ionic devices offer unique advantages in frontier fields such as brain-computer interfaces and biocompatible computing. Recently, the research team from the State Key Laboratory of Heavy Ion Science and Technology at the Institute of Modern Physics, Chinese Academy of Sciences, in collaboration with Lanzhou University, Hebei University of Geosciences, and other partners, successfully achieved stable ionic memristive effects in single-ion-track nanochannels. Through precise regulation, they realized programmable transitions in memristive and synaptic functions, providing a new technological pathway for the development of next-generation low-power neuromorphic computing hardware. The related results were published in the journal *Small* on July 22. Leveraging the Heavy Ion Research Facility in Lanzhou (HIRFL), the researchers...

2026-08-03

First Experimental Result Published from the High-Intensity Heavy-Ion Accelerator Facility

Recently, the research team from the Institute of Modern Physics (IMP) of the Chinese Academy of Sciences, together with collaborators, successfully produced and identified the rare isotope hafnium-153 using the High-Intensity Heavy-Ion Accelerator Facility (HIAF). This is the first physics result obtained during the commissioning of HIAF, demonstrating that China's new-generation high-intensity heavy-ion research facility is capable of exploring unknown nuclides and expanding the nuclear chart. It marks the official commencement of HIAF's scientific discovery journey. The result was published as a short communication in *Science Bulletin*. Figure: Position of hafnium-153 on the nuclear chart; the blue line indicates the boundary of known nuclides. Image | Hu Houyu, Li Hongfu. Atomic nuclei are composed of protons and neutrons, and different combinations of proton and neutron numbers form the diverse world of nuclides. Exploring unknown nuclides and investigating the boundaries of nuclear existence are important frontiers in nuclear physics. Hafnium-153 is located in the neutron-deficient heavy-mass region and is an important subject for studying the evolution of nuclear structure and the limits of nuclear stability. It had not been reported prior to this experiment. The discovery and precise measurement of this nuclide will help test nuclear theory models and deepen our understanding of nuclear structure regularities.

2026-08-03

Japanese research team experimentally confirms full-gap spin-triplet superconductivity in UBe13

On July 30, 2026, Kobe University and the Japan Atomic Energy Agency announced that a research team led by Professor Hideki Higashibata of the Graduate School of Science at Kobe University, along with Shoko Minami, who was a master's student at the time of the research, in collaboration with Yoshinori Haga, Research Director at the Japan Atomic Energy Agency, and researchers from Osaka University, experimentally confirmed for the first time the existence of a spin-triplet superconducting state with full-gap characteristics in the intermetallic compound UBe13. The findings were published in the Journal of the Physical Society of Japan on June 26 and were selected as an Editor's Choice paper. Since its discovery in 1983, UBe13 has been regarded as an important candidate material for spin-triplet superconductivity. Unlike conventional spin-singlet superconductivity...

2026-08-03

JAEA Develops 3D-Printed Disposable Aerosol Particle Size Classification Device

On July 30, 2026, the Japan Atomic Energy Agency announced the development of a palm-sized, 3D-printed disposable device named µSPLIT (micro splitter) that can separate airborne particles by particle size on-site and collect them onto filters for subsequent or direct measurement. The disposable classification and measurement device µSPLIT (left) separates aerosols by particle size through controlled intake flow rate, with particles collected on filters. (Right) The main unit can be directly connected to a radiation detector via a thin film. According to reports, µSPLIT measures approximately 12 cm × 3 cm × 3 cm and is integrally molded from transparent resin using stereolithography 3D printing technology...

2026-08-03